Literature DB >> 17706527

Impact of PET on radiation therapy planning in lung cancer.

Michael P Mac Manus1, Rodney J Hicks.   

Abstract

The superiority of PET imaging to structural imaging in many cancers is rapidly transforming the practice of radiotherapy planning, especially in lung cancer. Although most lung cancers are potentially treatable with radiation therapy, only patients who have truly locoregionally confined disease can be cured by this modality. PET improves selection for high-dose radiation therapy by excluding many patients who have incurable distant metastasis or extensive locoregional spread. In those patients suitable for definitive treatment, PET can help shape the treatment fields to avoid geographic miss and minimize unnecessary irradiation of normal tissues. PET will allow for more accurately targeted dose escalation studies in the future and could potentially lead to better long-term survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17706527     DOI: 10.1016/j.rcl.2007.05.002

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

1.  Metabolic Tumor Volume on PET Reduced More than Gross Tumor Volume on CT during Radiotherapy in Patients with Non-Small Cell Lung Cancer Treated with 3DCRT or SBRT.

Authors:  Pawinee Mahasittiwat; Shuanghu Yuan; Congying Xie; Timothy Ritter; Yue Cao; Randall K Ten Haken; Feng-Ming Spring Kong
Journal:  J Radiat Oncol       Date:  2013-06

Review 2.  Molecular imaging of pulmonary cancer and inflammation.

Authors:  Chaitanya R Divgi
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

Review 3.  Positron emission tomography-computed tomography in the management of lung cancer: An update.

Authors:  Punit Sharma; Harmandeep Singh; Sandip Basu; Rakesh Kumar
Journal:  South Asian J Cancer       Date:  2013-07

4.  Average CT in PET studies of colorectal cancer patients with metastasis in the liver and esophageal cancer patients.

Authors:  Elena Tonkopi; Pai-Chun Melinda Chi; Osama Mawlawi; Adam C Riegel; Eric M Rohren; Homer A Macapinlac; Tinsu Pan
Journal:  J Appl Clin Med Phys       Date:  2010-02-04       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.